Following the advice of its advisers, the FDA has rebuffed cangrelor, a blood-thinning drug from The Medicines Company, asking for more analysis and a new study before it’ll give the treatment a second chance.

…read more

Source: FDA rejects The Medicines Co.’s clot-buster, sending cangrelor back to the clinic


0 No comments